Sort by:
Mounjaro 2.5Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces
147.000 KWD
Mounjaro 2.5Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces Mounjaro is a weekly self–injectable pen used for weight loss. Active ingredients tirzepatide which works by regulating blood sugar and energy balance...
Mounjaro 5Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces
147.000 KWD
Mounjaro 5Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces Mounjaro is a weekly self–injectable pen used for weight loss. Active ingredients tirzepatide which works by regulating blood sugar and energy balance...
Mounjaro7.5mg /0.5Ml Injection Pre-Fill Pen 4 Pieces
147.000 KWD
Mounjaro 7.5Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces Mounjaro is a weekly self–injectable pen used for weight loss. Active ingredients tirzepatide which works by regulating blood sugar and energy balance...
Ozempic 1mg solution for injection
35.140 KWD
Ozempic 1mg solution for injection pre filled pen ( once per week) Ozempic 1mg solution for injection is a convenient and effective way to manage your diabetes. With just one...
Mounjaro 10 Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces
147.000 KWD
Mounjaro 10Mg/0.5Ml Injection Pre-Fill Pen 4 Pieces Mounjaro is a weekly self–injectable pen used for weight loss. Active ingredients tirzepatide which works by regulating blood sugar and energy balance...
Ozempic 0.5 mg Solution for Injection in Pre-filled Pen (Once weekly) (1.5 ml)
35.140 KWD
Ozempic 0.5 mg Solution for Injection in Pre-filled Pen (Once weekly) (1.5 ml) Get effective diabetes management with Ozempic 0.5 mg Solution for Injection in Pre-filled Pen. This once-weekly treatment...
Ozempic 0.25 mg Solution for Injection in Pre-filled Pen (Once weekly) (1.5 ml)
35.140 KWD
Ozempic 0.25 mg Solution for Injection in Pre-filled Pen (Once weekly) (1.5 ml) Maximize your diabetes treatment with Ozempic 0.25 mg Solution for Injection in Pre-filled Pen. Experience the convenience...
Ozempic (semaglutide) and Mounjaro (tirzepatide) are prescription medications used to treat type 2 diabetes in adults. They belong to a class of drugs called GLP-1 receptor agonists, which work by increasing insulin production, decreasing glucagon secretion, and slowing gastric emptying to help control blood sugar levels.
Ozempic:
- Active ingredient: semaglutide
- Administered via once-weekly subcutaneous injection
- Approved by the FDA in 2017 for the treatment of type 2 diabetes
- In clinical trials, Ozempic was shown to significantly improve HbA1c (average blood sugar) levels and facilitate weight loss in adults with type 2 diabetes
- Common side effects may include nausea, diarrhea, vomiting, constipation, and abdominal pain
Mounjaro:
- Active ingredient: tirzepatide
- Administered via once-weekly subcutaneous injection
- Approved by the FDA in 2022 for the treatment of type 2 diabetes
- In clinical trials, Mounjaro demonstrated superior improvements in HbA1c and body weight compared to other GLP-1 agonists and insulin products
- Mounjaro is a dual GIP and GLP-1 receptor agonist, providing a unique mechanism of action to help regulate blood sugar and promote weight loss
- Potential side effects may include nausea, diarrhea, decreased appetite, and injection site reactions
Both Ozempic and Mounjaro require a prescription from a healthcare provider. They should be used as part of a comprehensive diabetes management plan that includes diet, exercise, and potentially other medications. Patients should closely monitor their blood sugar levels and consult their doctor about the appropriate use and potential risks/benefits of these treatments.
